In Vitro Diagnostics | Market Insights | US | 2023
The COVID-19 pandemic has negatively impacted the US IVD market, resulting in test volumes and revenue declines in 2020. However, following a period of recovery, the market will grow modestly through 2031, driven by the aging US population, the rise in incidences of chronic and infectious, diseases and the shift toward value-based healthcare, which will fuel the uptake of newer tests with the development of automated IVD systems, improved diagnostic accuracy and reduced turnaround time. The continuous increase in the launch of IVD products being launched by key players is also fueling the growth of the market
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IVDs in the US from 2019 through 2031.
